Cargando…
Effect of desmopressin lyophilisate (MELT) plus anticholinergics combination on functional bladder capacity and therapeutic outcome as the first-line treatment for primary monosymptomatic nocturnal enuresis: A randomized clinical trial
PURPOSE: To assess the efficacy of desmopressin plus anticholinergic combination therapy as first-line treatment for children with primary monosymptomatic nocturnal enuresis (PMNE) and to analyze this combination's effect on functional bladder capacity (FBC). MATERIALS AND METHODS: A total of 9...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Urological Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100016/ https://www.ncbi.nlm.nih.gov/pubmed/33834643 http://dx.doi.org/10.4111/icu.20200303 |
_version_ | 1783688688859873280 |
---|---|
author | Shim, Myungsun Bang, Woo Jin Oh, Cheol Young Kang, Min Jae Cho, Jin Seon |
author_facet | Shim, Myungsun Bang, Woo Jin Oh, Cheol Young Kang, Min Jae Cho, Jin Seon |
author_sort | Shim, Myungsun |
collection | PubMed |
description | PURPOSE: To assess the efficacy of desmopressin plus anticholinergic combination therapy as first-line treatment for children with primary monosymptomatic nocturnal enuresis (PMNE) and to analyze this combination's effect on functional bladder capacity (FBC). MATERIALS AND METHODS: A total of 99 children with PMNE were prospectively enrolled from 2015 to 2019 and randomly allocated to a monotherapy group (n=49), with oral desmopressin lyophilisate (MELT) only; and a combination group (n=50), with desmopressin plus an anticholinergic (propiverine 5 mg). Efficacy and FBC were evaluated at 1 and 3 months after treatment initiation; the relapse rate was assessed at 6 months after treatment cessation. RESULTS: The combination therapy group showed a higher rate of complete response than the monotherapy group after 3 months of treatment (44.0% vs. 22.4%, p=0.002). A significant increase in mean FBC was observed only in the combination group, from 88.72±26.34 mL at baseline to 115.52±42.23 mL at 3 months of treatment (p=0.024). Combination therapy was significantly associated with treatment success at 3 months after treatment initiation (odds ratio [OR], 3.527; 95% confidence interval [CI], 1.203–6.983; p=0.011) and decreased risk of relapse at 6 months after treatment cessation (OR, 0.306; 95% CI, 0.213–0.894; p=0.021), by multivariable analysis. CONCLUSIONS: This study represents the first prospective, randomized controlled trial showing higher response rates and lower relapse rates with desmopressin plus anticholinergic combination therapy compared with desmopressin monotherapy as first-line treatment for children with PMNE. |
format | Online Article Text |
id | pubmed-8100016 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Korean Urological Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-81000162021-05-14 Effect of desmopressin lyophilisate (MELT) plus anticholinergics combination on functional bladder capacity and therapeutic outcome as the first-line treatment for primary monosymptomatic nocturnal enuresis: A randomized clinical trial Shim, Myungsun Bang, Woo Jin Oh, Cheol Young Kang, Min Jae Cho, Jin Seon Investig Clin Urol Original Article PURPOSE: To assess the efficacy of desmopressin plus anticholinergic combination therapy as first-line treatment for children with primary monosymptomatic nocturnal enuresis (PMNE) and to analyze this combination's effect on functional bladder capacity (FBC). MATERIALS AND METHODS: A total of 99 children with PMNE were prospectively enrolled from 2015 to 2019 and randomly allocated to a monotherapy group (n=49), with oral desmopressin lyophilisate (MELT) only; and a combination group (n=50), with desmopressin plus an anticholinergic (propiverine 5 mg). Efficacy and FBC were evaluated at 1 and 3 months after treatment initiation; the relapse rate was assessed at 6 months after treatment cessation. RESULTS: The combination therapy group showed a higher rate of complete response than the monotherapy group after 3 months of treatment (44.0% vs. 22.4%, p=0.002). A significant increase in mean FBC was observed only in the combination group, from 88.72±26.34 mL at baseline to 115.52±42.23 mL at 3 months of treatment (p=0.024). Combination therapy was significantly associated with treatment success at 3 months after treatment initiation (odds ratio [OR], 3.527; 95% confidence interval [CI], 1.203–6.983; p=0.011) and decreased risk of relapse at 6 months after treatment cessation (OR, 0.306; 95% CI, 0.213–0.894; p=0.021), by multivariable analysis. CONCLUSIONS: This study represents the first prospective, randomized controlled trial showing higher response rates and lower relapse rates with desmopressin plus anticholinergic combination therapy compared with desmopressin monotherapy as first-line treatment for children with PMNE. The Korean Urological Association 2021-05 2021-03-16 /pmc/articles/PMC8100016/ /pubmed/33834643 http://dx.doi.org/10.4111/icu.20200303 Text en © The Korean Urological Association, 2021 https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Shim, Myungsun Bang, Woo Jin Oh, Cheol Young Kang, Min Jae Cho, Jin Seon Effect of desmopressin lyophilisate (MELT) plus anticholinergics combination on functional bladder capacity and therapeutic outcome as the first-line treatment for primary monosymptomatic nocturnal enuresis: A randomized clinical trial |
title | Effect of desmopressin lyophilisate (MELT) plus anticholinergics combination on functional bladder capacity and therapeutic outcome as the first-line treatment for primary monosymptomatic nocturnal enuresis: A randomized clinical trial |
title_full | Effect of desmopressin lyophilisate (MELT) plus anticholinergics combination on functional bladder capacity and therapeutic outcome as the first-line treatment for primary monosymptomatic nocturnal enuresis: A randomized clinical trial |
title_fullStr | Effect of desmopressin lyophilisate (MELT) plus anticholinergics combination on functional bladder capacity and therapeutic outcome as the first-line treatment for primary monosymptomatic nocturnal enuresis: A randomized clinical trial |
title_full_unstemmed | Effect of desmopressin lyophilisate (MELT) plus anticholinergics combination on functional bladder capacity and therapeutic outcome as the first-line treatment for primary monosymptomatic nocturnal enuresis: A randomized clinical trial |
title_short | Effect of desmopressin lyophilisate (MELT) plus anticholinergics combination on functional bladder capacity and therapeutic outcome as the first-line treatment for primary monosymptomatic nocturnal enuresis: A randomized clinical trial |
title_sort | effect of desmopressin lyophilisate (melt) plus anticholinergics combination on functional bladder capacity and therapeutic outcome as the first-line treatment for primary monosymptomatic nocturnal enuresis: a randomized clinical trial |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100016/ https://www.ncbi.nlm.nih.gov/pubmed/33834643 http://dx.doi.org/10.4111/icu.20200303 |
work_keys_str_mv | AT shimmyungsun effectofdesmopressinlyophilisatemeltplusanticholinergicscombinationonfunctionalbladdercapacityandtherapeuticoutcomeasthefirstlinetreatmentforprimarymonosymptomaticnocturnalenuresisarandomizedclinicaltrial AT bangwoojin effectofdesmopressinlyophilisatemeltplusanticholinergicscombinationonfunctionalbladdercapacityandtherapeuticoutcomeasthefirstlinetreatmentforprimarymonosymptomaticnocturnalenuresisarandomizedclinicaltrial AT ohcheolyoung effectofdesmopressinlyophilisatemeltplusanticholinergicscombinationonfunctionalbladdercapacityandtherapeuticoutcomeasthefirstlinetreatmentforprimarymonosymptomaticnocturnalenuresisarandomizedclinicaltrial AT kangminjae effectofdesmopressinlyophilisatemeltplusanticholinergicscombinationonfunctionalbladdercapacityandtherapeuticoutcomeasthefirstlinetreatmentforprimarymonosymptomaticnocturnalenuresisarandomizedclinicaltrial AT chojinseon effectofdesmopressinlyophilisatemeltplusanticholinergicscombinationonfunctionalbladdercapacityandtherapeuticoutcomeasthefirstlinetreatmentforprimarymonosymptomaticnocturnalenuresisarandomizedclinicaltrial |